Back to Search Start Over

Federal Circuit dissects Myriad arguments.

Source :
Managing Intellectual Property; Apr2011, Issue 208, p74-74, 1p, 1 Chart
Publication Year :
2011

Abstract

The article discusses the case of Molecular Pathology v the USPTO involving the patent eligibility of isolated genes. Topics discussed include the oral argument result favoring Myriad Genetics, American Civil Liberties Union (ACLU) counsel Chris Hansen's claim that there are no differences between natural and isolated genes and the USPTO guidelines for patenting isolated genes.

Details

Language :
English
ISSN :
09605002
Issue :
208
Database :
Complementary Index
Journal :
Managing Intellectual Property
Publication Type :
Periodical
Accession number :
103296541